Guruprasad P. Aithal

32.3k total citations · 14 hit papers
304 papers, 16.5k citations indexed

About

Guruprasad P. Aithal is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Guruprasad P. Aithal has authored 304 papers receiving a total of 16.5k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Epidemiology, 120 papers in Hepatology and 70 papers in Pharmacology. Recurrent topics in Guruprasad P. Aithal's work include Liver Disease Diagnosis and Treatment (142 papers), Liver Disease and Transplantation (74 papers) and Drug-Induced Hepatotoxicity and Protection (63 papers). Guruprasad P. Aithal is often cited by papers focused on Liver Disease Diagnosis and Treatment (142 papers), Liver Disease and Transplantation (74 papers) and Drug-Induced Hepatotoxicity and Protection (63 papers). Guruprasad P. Aithal collaborates with scholars based in United Kingdom, United States and Spain. Guruprasad P. Aithal's co-authors include Christopher P. Day, Ann K. Daly, Raúl J. Andrade, Joe West, Patrick Kesteven, Einar S. Björnsson, Tim Card, Neil Kaplowitz, Gerd A. Kullak‐Ublick and Vidyasagar Ramappa and has published in prestigious journals such as The Lancet, Nature Medicine and Nature Communications.

In The Last Decade

Guruprasad P. Aithal

284 papers receiving 16.1k citations

Hit Papers

Liraglutide safety and efficacy in... 1999 2026 2008 2017 2015 1999 2009 2011 2019 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
    2015 1.6k citations Guruprasad P. Aithal, Richard Parker et al. profile →
  2. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
    1999 948 citations Guruprasad P. Aithal, Ann K. Daly et al. profile →
  3. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
    2009 732 citations Ann K. Daly, Munir Pirmohamed et al. profile →
  4. Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
    2011 713 citations Guruprasad P. Aithal, Raúl J. Andrade et al. Clinical Pharmacology & Therapeutics profile →
  5. EASL Clinical Practice Guidelines: Drug-induced liver injury
    2019 710 citations Raúl J. Andrade, Guruprasad P. Aithal et al. profile →
  6. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
    2007 578 citations Stephen Ryder, Guruprasad P. Aithal et al. profile →
  7. Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
    2008 545 citations Guruprasad P. Aithal, Philip Kaye et al. profile →
  8. Drug-induced liver injury
    2019 537 citations Raúl J. Andrade, Einar S. Björnsson et al. profile →
  9. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
    2014 454 citations Michael Allison, Guruprasad P. Aithal et al. profile →
  10. Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management
    2012 363 citations Guruprasad P. Aithal et al. profile →
  11. Drug-induced liver injury: recent advances in diagnosis and risk assessment
    2017 344 citations Gerd A. Kullak‐Ublick, Raúl J. Andrade et al. profile →
  12. Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study
    2020 280 citations Guruprasad P. Aithal et al. profile →
  13. Guidelines on the management of ascites in cirrhosis
    2020 240 citations Guruprasad P. Aithal, Emilie Wilkes et al. profile →
  14. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
    2021 171 citations Guruprasad P. Aithal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guruprasad P. Aithal United Kingdom 58 8.1k 5.0k 4.8k 3.0k 2.9k 304 16.5k
Einar S. Björnsson Iceland 65 7.9k 1.0× 6.3k 1.3× 6.8k 1.4× 1.3k 0.4× 2.6k 0.9× 311 17.4k
Ann K. Daly United Kingdom 74 4.1k 0.5× 9.9k 2.0× 2.0k 0.4× 2.9k 1.0× 4.5k 1.5× 282 20.5k
Christian P. Strassburg Germany 59 4.5k 0.6× 2.3k 0.5× 4.9k 1.0× 640 0.2× 2.2k 0.7× 355 13.0k
Herbert L. Bonkovsky United States 75 7.7k 1.0× 3.6k 0.7× 7.4k 1.5× 628 0.2× 1.6k 0.5× 369 20.0k
Ramón Bataller Spain 76 16.2k 2.0× 1.9k 0.4× 12.0k 2.5× 3.1k 1.0× 1.4k 0.5× 307 25.4k
Dominique Larrey France 56 4.1k 0.5× 4.1k 0.8× 4.1k 0.8× 514 0.2× 2.0k 0.7× 329 10.8k
Manuel Romero‐Gómez Spain 55 11.1k 1.4× 1.4k 0.3× 8.0k 1.7× 3.0k 1.0× 773 0.3× 375 14.7k
Geoffrey C. Farrell Australia 76 19.9k 2.5× 2.1k 0.4× 10.0k 2.1× 6.9k 2.3× 1.6k 0.5× 213 26.1k
Naga Chalasani United States 85 26.8k 3.3× 5.1k 1.0× 14.3k 3.0× 10.1k 3.4× 2.9k 1.0× 495 37.2k
Christopher P. Day United Kingdom 86 23.0k 2.8× 2.9k 0.6× 10.2k 2.1× 9.9k 3.3× 1.5k 0.5× 186 31.1k

Countries citing papers authored by Guruprasad P. Aithal

Since Specialization
Citations

This map shows the geographic impact of Guruprasad P. Aithal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guruprasad P. Aithal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guruprasad P. Aithal more than expected).

Fields of papers citing papers by Guruprasad P. Aithal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guruprasad P. Aithal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guruprasad P. Aithal. The network helps show where Guruprasad P. Aithal may publish in the future.

Co-authorship network of co-authors of Guruprasad P. Aithal

This figure shows the co-authorship network connecting the top 25 collaborators of Guruprasad P. Aithal. A scholar is included among the top collaborators of Guruprasad P. Aithal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guruprasad P. Aithal. Guruprasad P. Aithal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Richard, Guruprasad P. Aithal, Michael Allison, et al.. (2025). Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease. The American Journal of Gastroenterology.
2.
High, Juliet, Matthew Hammond, Lee Shepstone, et al.. (2025). Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study. BMJ Open Gastroenterology. 12(1). e001596–e001596.
3.
Hoad, Caroline L., Ourania Gouseti, Serafim Bakalis, et al.. (2024). Structuring white rice with gellan gum reduces the glycemic response in healthy humans. Food Research International. 196. 115090–115090. 4 indexed citations
4.
Abhishek, Abhishek, Matthew J. Grainge, Tim Card, et al.. (2024). Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation. RMD Open. 10(1). e003980–e003980. 3 indexed citations
5.
Allen, Richard J., Olivia C. Leavy, Nicholas M. Selby, et al.. (2023). Classifying the unclassifiable—a Delphi study to reach consensus on the fibrotic nature of diseases. QJM. 116(6). 429–435. 3 indexed citations
6.
Mehta, Ojasvi, Amrita Vijay, Weiya Zhang, et al.. (2023). Serum Metabolome Analysis Identified Amino-Acid Metabolism Associated With Pain in People With Symptomatic Knee Osteoarthritis – A Cross-Sectional Study. Journal of Pain. 24(7). 1251–1261. 9 indexed citations
7.
Gai, Zhibo, Sophia L. Samodelov, Irina Alecu, et al.. (2023). Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury. International Journal of Molecular Sciences. 24(3). 3013–3013. 5 indexed citations
8.
Aithal, Guruprasad P. & Anand V. Kulkarni. (2023). Drug-induced liver injury. Medicine. 51(5). 342–346. 3 indexed citations
9.
Knight, Holly, Joanne R Morling, Katy A. Jones, et al.. (2022). Characteristics of alcohol recovery narratives: Systematic review and narrative synthesis. PLoS ONE. 17(5). e0268034–e0268034. 4 indexed citations
10.
Hayashi, Paul H., M. Isabel Lucena, Robert J. Fontana, et al.. (2022). A revised electronic version of RUCAM for the diagnosis of DILI. Repositorio Institucional de la Universidad de Málaga (University of Málaga). 74 indexed citations
11.
12.
Kaye, Philip, Emilie Wilkes, Jonathan Evans, et al.. (2021). Estimating the clinical prevalence of Wilson’s disease in the UK. JHEP Reports. 3(5). 100329–100329. 7 indexed citations
13.
Urbanowicz, Richard A., Theocharis Tsoleridis, Hannah Jackson, et al.. (2021). Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection. Science Translational Medicine. 13(609). eabj0847–eabj0847. 20 indexed citations
14.
15.
Aithal, Guruprasad P., et al.. (2020). Investigation of Oxidative Stress-Related Candidate Genes as Risk Factors for Drug-Induced Liver Injury due to Co-Amoxiclav. DNA and Cell Biology. 39(3). 349–354. 11 indexed citations
16.
Alyami, Jaber, Gleb E. Yakubov, Susan E. Pritchard, et al.. (2019). Glycaemic, gastrointestinal, hormonal and appetitive responses to pearl millet or oats porridge breakfasts: a randomised, crossover trial in healthy humans. British Journal Of Nutrition. 122(10). 1142–1154. 25 indexed citations
17.
Hammond, Thomas, Xiaoli Meng, Rosalind E. Jenkins, et al.. (2014). Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from a Drug Acyl Glucuronide Metabolite: Multiple Albumin Adductions in Diclofenac Patients. Journal of Pharmacology and Experimental Therapeutics. 350(2). 387–402. 50 indexed citations
18.
Pereira, Stephen P., et al.. (2012). Safety and long term efficacy of porfimer sodium photodynamic therapy in locally advanced biliary tract carcinoma. Photodiagnosis and Photodynamic Therapy. 9(4). 287–292. 19 indexed citations
19.
Pirmohamed, Munir, Guruprasad P. Aithal, Elijah R. Behr, Ann K. Daly, & Dan M. Roden. (2011). The Phenotype Standardization Project: Improving Pharmacogenetic Studies of Serious Adverse Drug Reactions. Clinical Pharmacology & Therapeutics. 89(6). 784–785. 46 indexed citations
20.
Aloysius, Mark M., Abed M. Zaitoun, Ian J. Beckingham, et al.. (2007). The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 451(5). 943–948. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Einar S. Björnsson Breakdown of academic impact, for papers by Ann K. Daly Breakdown of academic impact, for papers by Christian P. Strassburg Breakdown of academic impact, for papers by Herbert L. Bonkovsky Breakdown of academic impact, for papers by Ramón Bataller Breakdown of academic impact, for papers by Dominique Larrey Breakdown of academic impact, for papers by Manuel Romero‐Gómez Breakdown of academic impact, for papers by Geoffrey C. Farrell Breakdown of academic impact, for papers by Naga Chalasani Breakdown of academic impact, for papers by Christopher P. Day
Rankless by CCL
2026